Atrial natriuretic peptide protects against Staphylococcus aureus-induced lung injury and endothelial barrier dysfunction
about
Nonstructural protein 1 (NS1)-mediated inhibition of c-Abl results in acute lung injury and priming for bacterial co-infections: insights into 1918 H1N1 pandemic?Cell-type-specific crosstalk between p38 MAPK and Rho signaling in lung micro- and macrovascular barrier dysfunction induced by Staphylococcus aureus-derived pathogens.Lipoteichoic acid from Staphylococcus aureus induces lung endothelial cell barrier dysfunction: role of reactive oxygen and nitrogen speciesRole of microtubules in attenuation of PepG-induced vascular endothelial dysfunction by atrial natriuretic peptide.Nogo-B protects mice against lipopolysaccharide-induced acute lung injuryEffects of atrial natriuretic peptide on inter-organ crosstalk among the kidney, lung, and heart in a rat model of renal ischemia-reperfusion injury.Endothelial actions of atrial and B-type natriuretic peptidesC-type natriuretic peptide protects the retinal pigment epithelium against advanced glycation end product-induced barrier dysfunction.Atrial natriuretic peptide attenuates agonist-induced pulmonary edema in mice with targeted disruption of the gene for natriuretic peptide receptor-ABeneficial Effects of Combined AT1 Receptor/Neprilysin Inhibition (ARNI) Versus AT1 Receptor Blockade Alone in the Diabetic Eye.Control of vascular permeability by atrial natriuretic peptide via a GEF-H1-dependent mechanism.Emerging therapeutic strategies to prevent infection-related microvascular endothelial activation and dysfunction.Lipoteichoic acids as a major virulence factor causing inflammatory responses via Toll-like receptor 2.Opposite effects of ANP receptors in attenuation of LPS-induced endothelial permeability and lung injury.Low-dose human atrial natriuretic peptide for the prevention of postoperative cardiopulmonary complications in chronic obstructive pulmonary disease patients undergoing lung cancer surgery.HIV induces production of IL-18 from intestinal epithelial cells that increases intestinal permeability and microbial translocation.
P2860
Q30368379-FED33D43-6324-44CF-B852-1AFE5F93B228Q33822820-01D35B57-7289-451C-BC9F-712B5F9EA48AQ34482086-854E2557-3305-44AC-A6D4-68F01FA06004Q34715709-F6C3DC6A-F39C-4236-B866-2FCC40F2AE91Q35852315-D5A0D06A-6FE2-4FFF-A0CE-95F791514397Q35883578-900AD2A8-DB42-476B-9FC3-75BD2CD336CBQ36159149-98545CAC-F7DB-46D6-857C-14BE0001BBAAQ36497572-EFBC1131-BB0F-4526-A888-95EF3408B181Q36599906-4116318A-B5C7-4890-B704-8F67B8FB1EC3Q37503374-91B7FE57-E642-468A-9C5E-1492EF285B4CQ37596383-DF293E8D-9AA3-4EEF-9D4B-F35544CAC8F6Q38122283-D6FA0F79-C84A-4FA6-A427-B13A6CA1F756Q38920945-D82FD3E9-0B5C-4349-90FE-FC3BD991010CQ41078913-B0C47FB6-6126-44D5-9F3C-CCB70EE2FB66Q43837354-1C249C49-BD34-4B9C-B6A8-529F479787C0Q52690423-2F0A5525-AF22-40BC-84FE-6787972F4860
P2860
Atrial natriuretic peptide protects against Staphylococcus aureus-induced lung injury and endothelial barrier dysfunction
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Atrial natriuretic peptide pro ...... ndothelial barrier dysfunction
@ast
Atrial natriuretic peptide pro ...... ndothelial barrier dysfunction
@en
type
label
Atrial natriuretic peptide pro ...... ndothelial barrier dysfunction
@ast
Atrial natriuretic peptide pro ...... ndothelial barrier dysfunction
@en
prefLabel
Atrial natriuretic peptide pro ...... ndothelial barrier dysfunction
@ast
Atrial natriuretic peptide pro ...... ndothelial barrier dysfunction
@en
P2093
P2860
P1476
Atrial natriuretic peptide pro ...... ndothelial barrier dysfunction
@en
P2093
Anna A Birukova
Junjie Xing
Nurgul Moldobaeva
P2860
P304
P356
10.1152/JAPPLPHYSIOL.00284.2010
P407
P577
2010-11-04T00:00:00Z